Increased excitability was also associated with high levels of plasma biomarkers (blood phosphorylated tau and GFAP) which are sensitive to incipient AD pathology40–42,54,55 and disease progression, especially p-tau21739,40. The gene discussed is MAPT; the disease is Alzheimer disease.